Psorcast Mobile Study

Description

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Conditions

Psoriatic Arthritis, Psoriasis, Psoriatic Conditions, Dermatologic Disease, Rheumatologic Disease, Psoriatic Nail, Plaque Psoriasis, Joint Pain, Dactylitis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Psorcast Study: A Smartphone-based Study of Psoriasis and Psoriatic Arthritis

Psorcast Mobile Study

Condition
Psoriatic Arthritis
Intervention / Treatment

-

Contacts and Locations

Seattle

Sage Bionetworks, Seattle, Washington, United States, 98109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult age 18 and older who consent to participate in the study
  • * Own a compatible iPhone or iPod Touch device running iOS 12.2 or above
  • * Be able to read and understand an official language of the country of participation
  • * Age 17 years or younger
  • * Not a resident of the a country where the app is approved for use
  • * Not have a personal (i.e., not shared) iPhone (4s or newer running iOS 8.0 or later)
  • * Not be able to read and understand an official language of the country of participation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Sage Bionetworks,

Solveig Sieberts, Ph.D, PRINCIPAL_INVESTIGATOR, Sage Bionetworks

Jose Scher, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Medical Center

Joseph Merola, MD, MMSc, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital & Harvard Medical School

Study Record Dates

2027-01-31